Can a breath test predict lung scarring? new study seeks answers

NCT ID NCT06644144

Recruiting now Knowledge-focused Sponsor: Amsterdam UMC, location VUmc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study aims to find early biomarkers that can predict if a person's lung scarring (pulmonary fibrosis) will get worse quickly. Researchers will follow 450 adults with various types of interstitial lung disease, including IPF and other fibrotic conditions. Participants will provide blood samples, lung function tests, CT scans, and breath analysis over time. The goal is to better understand who is at risk for rapid decline and to improve personalized treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HYPERSENSITIVITY PNEUMONITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibrotic hypersensitivity pneumonitis hypersensitivity pneumonitis idiopathic pulmonary fibrosis interstitial lung disease interstitial lung disease 2 non-specific interstitial pneumonia pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HYPERSENSITIVITY PNEUMONITIS CTD-ILD IDIOPATHIC NSIP INTERSTITIAL LUNG DISEASE INTERSTITIAL LUNG FIBROSIS IPF PULMONARY FIBROSIS PULMONARY FIBROSIS IDIOPATHIC FAMILIAL PULMONARY FIBROSIS, IDIOPATHIC UNCLASSIFIABLE ILD

Contacts and locations

Locations

Amsterdam UMC, locatie VUmc
RECRUITING

Amsterdam, North Holland, 1081 HV, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.